Ningbo MedicalSystem Biotechnology Co Ltd
Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass… Read more
Ningbo MedicalSystem Biotechnology Co Ltd (300439) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.017x
Based on the latest financial reports, Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a cash flow conversion efficiency ratio of 0.017x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.96 Million) by net assets (CN¥2.95 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ningbo MedicalSystem Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Ningbo MedicalSystem Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ningbo MedicalSystem Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ningbo MedicalSystem Biotechnology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PKSHA TECHNOLOGY INC.
F:762
|
N/A |
|
Triveni Engineering & Industries Limited
NSE:TRIVENI
|
0.012x |
|
K&F Growth Acquisition Corp. II Class A Ordinary shares
NASDAQ:KFII
|
-0.002x |
|
Cartesian Growth Corporation III Class A Ordinary Shares
NASDAQ:CGCT
|
-0.001x |
|
Dareway Software Co Ltd
SHG:688579
|
0.006x |
|
Checkpoint Therapeutics Inc
NASDAQ:CKPT
|
-0.717x |
|
Bumble Inc
NASDAQ:BMBL
|
0.074x |
|
Flughafen Wien Aktiengesellschaft
PINK:FGWLF
|
0.064x |
Annual Cash Flow Conversion Efficiency for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.93 Billion | CN¥397.81 Million | 0.136x | -42.06% |
| 2023-12-31 | CN¥2.71 Billion | CN¥633.53 Million | 0.234x | +4.43% |
| 2022-12-31 | CN¥2.52 Billion | CN¥564.67 Million | 0.224x | +3.95% |
| 2021-12-31 | CN¥2.39 Billion | CN¥515.48 Million | 0.216x | -60.12% |
| 2020-12-31 | CN¥1.69 Billion | CN¥912.07 Million | 0.541x | +24.86% |
| 2019-12-31 | CN¥1.39 Billion | CN¥601.17 Million | 0.433x | +134.69% |
| 2018-12-31 | CN¥2.27 Billion | CN¥418.80 Million | 0.185x | +428.61% |
| 2017-12-31 | CN¥2.29 Billion | CN¥-128.40 Million | -0.056x | -4283.55% |
| 2016-12-31 | CN¥1.83 Billion | CN¥2.45 Million | 0.001x | -99.03% |
| 2015-12-31 | CN¥1.29 Billion | CN¥177.55 Million | 0.138x | -50.86% |
| 2014-12-31 | CN¥415.13 Million | CN¥116.51 Million | 0.281x | -13.52% |
| 2013-12-31 | CN¥308.32 Million | CN¥100.06 Million | 0.325x | +40.55% |
| 2012-12-31 | CN¥202.58 Million | CN¥46.78 Million | 0.231x | -48.63% |
| 2011-12-31 | CN¥110.84 Million | CN¥49.82 Million | 0.450x | -- |